Capsaicin, the most pungent ingredient in red peppers, has been used f
or centuries to remedy pain. Recently, its role has come under reinves
tigation due to evidence that the drug acts selectively on a subpopula
tion of primary sensory neurons with a nociceptive function. These neu
rons, besides generating pain sensations, participate through an antid
romic activation in the process known as neurogenic inflammation. The
first exposure to capsaicin intensely activates these neurons in both
senses (orthodromic:pain sensation; antidromic: local reddening, oedem
a etc.). After the first exposure, the neurons become insensitive to a
ll further stimulation (including capsaicin itself). This evidence led
to the proposal of capsaicin as a prototype of an agent producing sel
ective analgesia. This perspective is radically different from previou
s 'folk medicine' cures, where the drug was used as a counter-irritati
ng agent (i.e. for muscular pain). The new concept requires that capsa
icin be repeatedly applied on the painful area to obtain the desensiti
sation of the sensory neurons. Following this idea, capsaicin has been
used successfully in controlling pain in postherpetic neuralgia, diab
etic neuropathy and other conditions of neuropathic pain. Furthermore,
evidence indicates that capsaicin could also control the pain of oste
oarthritis. Finally, repeated applications of the drug to the nasal mu
cosa result in the prevention of cluster headache attacks. On the basi
s of this evidence, capsaicin appears to be a promising prototype for
obtaining selective analgesia in localised pain syndromes.